Volume 67, Issue 1, Pages (January 2005)

Slides:

Advertisements

Similar presentations

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Volume 63, Issue 6, Pages (June 2003)

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Volume 63, Issue 3, Pages (March 2003)

Volume 70, Pages S21-S25 (December 2006)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 72, Issue 9, Pages (November 2007)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

Volume 71, Issue 11, Pages (June 2007)

Volume 66, Issue 6, Pages (December 2004)

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia Michiel van den Berg, MD, Diana G. Franken,

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Volume 59, Issue 4, Pages (April 2001)

Altered tryptophan metabolism and CKD-associated fatigue

Fructose intake as a risk factor for kidney stone disease

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Volume 93, Issue 1, Pages (January 2018)

Volume 87, Issue 1, Pages (January 2015)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 81, Issue 9, Pages (May 2012)

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Prehypertension: is it relevant for nephrologists?

Volume 61, Issue 5, Pages (May 2002)

Volume 64, Issue 2, Pages (August 2003)

Peritoneal dialysis in Mexico

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

Volume 62, Issue 4, Pages (October 2002)

Volume 80, Issue 10, Pages (November 2011)

Volume 68, Issue 5, Pages (November 2005)

Volume 70, Issue 3, Pages (August 2006)

Is complement a target for therapy in renal disease?

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Volume 75, Issue 7, Pages (April 2009)

Ziad A. Massy Kidney International

Hisataka Kobayashi, Peter L. Choyke Kidney International

Volume 70, Issue 10, Pages (November 2006)

Ronen Levi, Justin Silver Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 67, Issue 1, Pages 259-264 (January 2005) Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease Frank Stam, Coen Van Guldener, Piet M. Ter Wee, Cornelis Jakobs, Kees De Meer, Coen D.A. Stehouwer, M.D. Kidney International Volume 67, Issue 1, Pages 259-264 (January 2005) DOI: 10.1111/j.1523-1755.2005.00076.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Schematic overview of the homocysteine metabolism. Abbreviations are: THF, tetrahydrofolate; MTHFr, 5,10-methylene-tetrahydrofolate reductase. Kidney International 2005 67, 259-264DOI: (10.1111/j.1523-1755.2005.00076.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Individual changes in remethylation and transmethylation rate in end-stage renal disease (ESRD) patients and control subjects before and after treatment with folic acid (5mg/day). Means with SD are depicted as bars. Kidney International 2005 67, 259-264DOI: (10.1111/j.1523-1755.2005.00076.x) Copyright © 2005 International Society of Nephrology Terms and Conditions